title: HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
abstract: BACKGROUND
  HLAMatchmaker is a recently developed computer-based algorithm to determine donor-recipient HLA compatibility at the molecular level. Originally designed for highly alloimmunized patients, this algorithm is based on the concept that immunogenic epitopes are represented by amino acid triplets on exposed parts of protein sequences of HLA-A, -B, and -C chains accessible to alloantibodies. Donor HLA compatibility is determined by intralocus and interlocus comparisons of triplets in polymorphic sequence positions. For most patients, HLAMatchmaker can identify certain mismatched HLA antigens that are zero-triplet mismatches to the patient's HLA phenotype and should, therefore, be considered fully histocompatible. The present study was designed to determine how class I HLA matching at the triplet level affects kidney transplant outcome.
  
  
  METHODS
  We analyzed two multicenter databases of zero-HLA-DR-mismatched kidneys transplanted from 1987 to 1999. One database consisted of 31,879 primary allografts registered by U.S. transplant centers in the United Network for Organ Sharing database and the other consisted of 15,872 transplants in the Eurotransplant program.
  
  
  RESULTS
  HLA-A,B mismatched kidneys that were compatible at the triplet level exhibited almost identical graft survival rates as the zero-HLA-A,B antigen mismatches defined by conventional criteria. This beneficial effect of triplet matching was seen for both nonsensitized and sensitized patients and also for white and nonwhite patients.
  
  
  CONCLUSIONS
  These findings suggest that the application of HLAMatchmaker will increase the number of successful transplants, at least in the HLA-DR match combinations.
authors.affiliation: University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA. Duquesnoyr@msx.upmc.edu.
authors.forename: Rene J
authors.initials: RJ
authors.lastname: Duquesnoy
authors.forename: Steve
authors.initials: S
authors.lastname: Takemoto
authors.forename: Peter
authors.initials: P
authors.lastname: de Lange
authors.forename: Ilias I N
authors.initials: II
authors.lastname: Doxiadis
authors.forename: Geziena M Th
authors.initials: GM
authors.lastname: Schreuder
authors.forename: Guido G
authors.initials: GG
authors.lastname: Persijn
authors.forename: Frans H J
authors.initials: FH
authors.lastname: Claas
mesh_terms: D000465:Algorithms; D000595:Amino Acid Sequence; D016208:Databases, Factual; D000939:Epitopes / Q000032:analysis / Q000235:genetics; D006085:Graft Survival / Q000276:immunology; D015234:HLA-A Antigens / Q000032:analysis* / Q000737:chemistry; D015235:HLA-B Antigens / Q000032:analysis* / Q000737:chemistry; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality*
chemical_list: D000939:Epitopes; D015234:HLA-A Antigens; D015235:HLA-B Antigens